drugset / Trial / NCT01323205
Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to explore the safety, tolerability, and potential clinical efficacy of JNJ 40411813 in schizophrenic patients.
Timeline
- Start
- 2011-05
- Primary completion
- 2012-11
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-40411813 | Small molecule | 150 mg | Oral |
| Background | Amisulpride | Small molecule | — | — |
| Background | Aripiprazole | Other / unclassified | — | — |
| Background | Benperidol | Small molecule | — | — |
| Background | CLOTHIAPINE | Small molecule | — | — |
| Background | Chlorpromazine | Small molecule | — | — |
| Background | Clozapine | Other / unclassified | — | — |
| Background | Flupentixol | Unknown | — | — |
| Background | Fluphenazine Decanoate | Small molecule | — | — |
| Background | Haloperidol | Other / unclassified | — | — |
| Background | Levomepromazine | Small molecule | — | — |
| Background | Melperone | Small molecule | — | — |
| Background | Olanzapine | Small molecule | — | — |
| Background | Paliperidone | Unknown | — | — |
| Background | Pipamperone | Small molecule | — | — |
| Background | Quetiapine | Small molecule | — | — |
| Background | Risperidone | Other / unclassified | — | — |
| Background | Zuclopenthixol | Unknown | — | — |